Immunomodulatory Effects of theAgaricus blazeiMurrill-Based Mushroom Extract AndoSan in Patients with Multiple Myeloma Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation: A Randomized, Double Blinded Clinical Study

The Polar High Molecular Weight Fraction of theAgaricus blazeiMurill Extract, AndoSan™, Reduces the Activity of the Tumor-Associated Protease, Legumain, in RAW 264.7 Cells

(2015) Lise Berven et al.   JOURNAL OF MEDICINAL FOOD

Improved long-term survival in multiple myeloma up to the age of 80 years

(2014) S Y Kristinsson et al.   LEUKEMIA

Induction of Malignant Plasma Cell Proliferation by Eosinophils

(2013) Tina W. Wong et al.   PLoS One

Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance

(2013) C Bryant et al.   Blood Cancer Journal

The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma

(2012) K Giannopoulos et al.   BRITISH JOURNAL OF CANCER

Computational Biology of Genome Expression and Regulation—A Review of Microarray Bioinformatics

(2012) Junbai Wang   JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY

A Novel Mouse Model for Multiple Myeloma (MOPC315.BM) That Allows Noninvasive Spatiotemporal Detection of Osteolytic Disease

(2012) Peter O. Hofgaard et al.   PLoS One

Phase I Clinical Study of the Dietary Supplement,Agaricus blazeiMurill, in Cancer Patients in Remission

(2011) Satoshi Ohno et al.   Evidence-based Complementary and Alternative Medicine

A Requisite Role for Induced Regulatory T Cells in Tolerance Based on Expanding Antigen Receptor Diversity

(2011) Dipica Haribhai et al.   IMMUNITY

Multiple Myeloma

(2011) Antonio Palumbo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Agaritine purified from Agaricus blazei Murrill exerts anti-tumor activity against leukemic cells

(2010) Masahiro Endo et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Why not treat human cancer with interleukin-1 blockade?

(2010) Charles A. Dinarello   CANCER AND METASTASIS REVIEWS

247 The medicinal and antitumour mushroom, agaricus blazei murill, activates NF-KB via TLR2 in monocytic cells and induces expression of cell surface markers and production of cytokines in human monocyte-derived dendritic cells (MDDC) in vitro

(2010) G. Hetland et al.   EJC SUPPLEMENTS

Effect of an Extract Based on the Medicinal Mushroom Agaricus blazei Murill on Expression of Cytokines and Calprotectin in Patients with Ulcerative Colitis and Crohn’s disease

(2010) D. T. Førland et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

An extract based on the medicinal mushroom Agaricus blazei Murill stimulates monocyte-derived dendritic cells to cytokine and chemokine production in vitro

(2009) D.T. Førland et al.   CYTOKINE

Increased Plasma-Immune Cytokines throughout the High-Dose Melphalan-Induced Lymphodepletion in Patients with Multiple Myeloma: A Window for Adoptive Immunotherapy

(2009) M. Condomines et al.   JOURNAL OF IMMUNOLOGY

Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component

(2009) John A. Lust et al.   MAYO CLINIC PROCEEDINGS

In vitroinhibition of CYP3A4 by herbal remedies frequently used by cancer patients

(2009) Silje Engdal et al.   PHYTOTHERAPY RESEARCH

Indications de l’anakinra

(2009) Karine Chauffier et al.   PRESSE MEDICALE

Inhibitory Effect ofAgaricu blazeiMurill Components on Abnormal Collagen Fiber Formation in Human Hepatocarcinoma Cells

(2008) Kenji SORIMACHI et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

The Medicinal MushroomAgaricus blazeiMurrill: Review of Literature and Pharmaco-Toxicological Problems

(2007) F. Firenzuoli et al.   Evidence-based Complementary and Alternative Medicine